Novartis India net profit falls 65pc to Rs 6.78 crore in Q4 Ruchika Sharma22 Jun 2020 9:30 AM ISTRevenue from operations stood at Rs 93.70 crore for the quarter under consideration. It was Rs 110.38 crore for the same period a year ago, Novartis...
Glenmark Pharmaceuticals gets USFDA nod for Fingolimod Capsules Ruchika Sharma19 Jun 2020 3:14 PM ISTMumbai: Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA)...
Novartis Cosentyx gets USFDA nod to treat active non-radiographic axial spondyloarthritis Ruchika Sharma17 Jun 2020 5:43 PM ISTCosentyx met the primary endpoint achieving statistically significant improvements versus placebo in the signs and symptoms of nr-axSpA, as measured...
Sandoz Canada gets approval to launch oncology biosimilars Ziextenzo, Riximyo Ruchika Sharma11 Jun 2020 9:30 AM ISTSandoz Canada received a Notice of Compliance from Health Canada on April 21, 2020, for the use of Ziextenzo to reduce the incidence of febrile...
Novartis Cosentyx gets EU nod to treat active non-radiographic axial spondyloarthritis Ruchika Sharma3 May 2020 10:00 AM ISTBasel: Novartis has announced the European Commission (EC) has approved Cosentyx® (secukinumab) for the treatment of adult patients with active...
Novartis Kymriah gets USFDA RMAT designation in follicular lymphoma Medical Dialogues Bureau26 April 2020 11:00 AM ISTKymriah, which is designed to be a one-time treatment, is the first-ever FDA-approved CAR-T cell therapy.
Novartis gets USFDA nod to start randomized trial of malaria drug hydroxychloroquine against COVID-19 Ruchika Sharma20 April 2020 2:34 PM ISTZurich: Novartis has won the go-ahead from the U.S. Food and Drug Administration to conduct a randomized trial of malaria drug hydroxychloroquine...
Inj Voveran Ban: Delhi High Court denies relief to manufacturer Themis Medicare, Dismisses Petition Meghna A Singhania12 July 2019 6:01 PM ISTNew Delhi: Denying relief to Themis Medicare, the manufacturer of the popular painkiller Inj Voveran 1ml (Diclofenac), that as marketed by Novartis...
9 arrested for selling drugs meant for defence, ESIC hospitals Medical Dialogues Bureau25 May 2019 10:00 AM ISTThane: The Navi Mumbai police in Maharashtra claimed to have busted an inter-state racket of illegal sale of medicines meant for defence and ESIC...
Allegations of Pharma Collusion for Fixing Price of Vidagliptin: Court dismisses Abbotts plea again CCI Probe Meghna A Singhania25 Nov 2018 8:18 PM ISTNew Delhi: Quashing the petition filed by leading drug maker Abbott, that wanted to stall the CCI probe into alleged carterlisation to fix the prices...
Ban on Voveran 1ml Injection- Patient Safety or Clash of Brands? Vinay10 Aug 2018 5:04 PM ISTWith Voveran being one of the preferred brands of choice of majority of physicians, the healthcare industry is also in the horns of a dilemma-“ Is The...
Understanding Diclofenac- the most popular NSAID painkiller Hina Zahid2 Aug 2018 3:11 PM ISTOver the years, novel methods for chemical synthesis and improved screening technologies have spurred the use of various kinds of pain management...
